Evidence map›Paper›PMID 23797153›Full record

ArticleExperimental neurology2013

Paxillin phosphorylation counteracts proteoglycan-mediated inhibition of axon regeneration.

Tomoharu Kuboyama, Xueting Luo, Kevin Park, Murray G Blackmore, Takuro Tojima, Chihiro Tohda, John L Bixby, Vance P Lemmon, Hiroyuki Kamiguchi

Abstract read
In one paragraph

Article in Experimental neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Paxillin: a crossroad in pathological cell migration.Journal of hematology & oncology · 2017
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Tomoharu KuboyamaLaboratory for Neuronal Growth Mechanisms, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama, Toyama, Toyama 930-0194, Japan.
Xueting Luo
Kevin Park
Murray G Blackmore
Takuro Tojima
Chihiro Tohda
John L Bixby
Vance P Lemmon
Hiroyuki Kamiguchi
Neurological Surgery · USRIKEN Center for Brain Science · JPUniversity of Miami · USJapan Science and Technology Agency · JPMarquette University · USUniversity of Toyama · JP

Funding

Novel Gene Targets for CNS Axonal RegenerationR01HD057632 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BIXBY, JOHN L, LEMMON, VANCE P · 2007 to 2018
$4.7M
Regeneration and Reconnection of Damaged Optic NerveR01EY022961 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PARK, KEVIN KYUNG · 2013 to 2019
$2.1M
NEI NIH HHS R01 EY022961NICHD NIH HHS HD057632NICHD NIH HHS R01 HD057632
6 · The paper itself

Abstract

In the adult central nervous system, the tips of axons severed by injury are commonly transformed into dystrophic endballs and cease migration upon encountering a rising concentration gradient of inhibitory proteoglycans. However, intracellular signaling networks mediating endball migration failure remain largely unknown. Here we show that manipulation of protein kinase A (PKA) or its downstream adhesion component paxillin can reactivate the locomotive machinery of endballs in vitro and facilitate axon growth after injury in vivo. In dissociated cultures of adult rat dorsal root ganglion neurons, PKA is activated in endballs formed on gradients of the inhibitory proteoglycan aggrecan, and pharmacological inhibition of PKA promotes axon growth on aggrecan gradients most likely through phosphorylation of paxillin at serine 301. Remarkably, pre-formed endballs on aggrecan gradients resume forward migration in response to PKA inhibition. This resumption of endball migration is associated with increased turnover of adhesive point contacts dependent upon paxillin phosphorylation. Furthermore, expression of phosphomimetic paxillin overcomes aggrecan-mediated growth arrest of endballs, and facilitates axon growth after optic nerve crush in vivo. These results point to the importance of adhesion dynamics in restoring endball migration and suggest a potential therapeutic target for axon tract repair.

Indexed as

AggrecansAnimalsAxonsCell MovementCyclic AMP-Dependent Protein KinasesFemaleGanglia, SpinalNerve RegenerationNeuronsPaxillinPhosphorylationProteoglycansRatsRats, Sprague-DawleyAggrecansCyclic AMP-Dependent Protein KinasesPaxillinProteoglycansAggrecanAxon regenerationDystrophic endballOptic nervep21-activated kinasePaxillinPoint contactProtein kinase A

Identifiers

PMID23797153
PMCPMC3773816
OpenAlexW2086723759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.